Non-ownership Filings
| License Agreement with Allogene Therapeutics | Mar. 24, 2020 |
| Consolidation of Trading Lines | Feb. 21, 2020 |
| AIM Block Admission Return / Total Voting Rights | Feb. 20, 2020 |
| MaxCyte to Present at BIO CEO & Investor Conf | Feb. 05, 2020 |
| Trading Update | Jan. 20, 2020 |
| New Executive Vice President and Trial Update | Dec. 19, 2019 |
| Agreement with KSQ Therapeutics | Dec. 04, 2019 |
Ownership Update Filings
| Grant Of Options | Jan. 24, 2020 |
| Holding(s) in Company | Jan. 22, 2020 |
| Holding(s) in Company | Jan. 22, 2020 |
| Holding(s) in Company | Jan. 22, 2020 |
| Director/PCA transaction initial notification | Dec. 16, 2019 |
| Director Dealings | Mar. 19, 2019 |
| Director Dealings | Dec. 17, 2018 |